{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-012904","form_type":"8-K","ticker":"ZVRA","cik":"0001434647","company_name":"ZEVRA THERAPEUTICS, INC.","filed_at":"2023-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.854857+00:00","generated_at":"2026-06-15T12:43:04.794044+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Zevra CEO Richard Pascoe resigns effective June 1, 2023; two directors not standing for re-election","bullets":["CEO Richard Pascoe resigned effective June 1, 2023; transition agreement provides 12 months base salary, pro-rated bonus, extended option exercise period.","Directors Matthew Plooster and Joseph Saluri will not stand for re-election at 2024 annual meeting; will resign once board finds replacements.","Board to immediately search for director candidates to fill the pending vacancies."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-012904","json":"https://secwatch.observer/filing/0001437749-23-012904.json","markdown":"https://secwatch.observer/filing/0001437749-23-012904.md","text":"https://secwatch.observer/filing/0001437749-23-012904.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923012904/0001437749-23-012904-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923012904/zvra20230507_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T12:43:04.794044+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"277223a443","claim":"Matthew R. Plooster departed as Director at ZEVRA THERAPEUTICS, INC..","evidence_excerpt":"on May 3, 2023, Matthew R. Plooster and Joseph B. Saluri, each a Class III director of the Company, notified the Company’s Board of Directors (the “Board”) that they do not intend to stand for re-election at the Company’s 2024 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923012904/0001437749-23-012904-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will not stand for re-election and will resign"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"6e232e64bf","claim":"Richard W. Pascoe resigned as Chief Executive Officer at ZEVRA THERAPEUTICS, INC..","evidence_excerpt":"On May 5, 2023, Richard W. Pascoe, the Chief Executive Officer of Zevra Therapeutics, Inc. (the “Company” or “Zevra”), resigned as the Company’s Chief Executive Officer, effective as of June 1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923012904/0001437749-23-012904-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"dbcb5f411a","claim":"Joseph B. Saluri departed as Director at ZEVRA THERAPEUTICS, INC..","evidence_excerpt":"on May 3, 2023, Matthew R. Plooster and Joseph B. Saluri, each a Class III director of the Company, notified the Company’s Board of Directors (the “Board”) that they do not intend to stand for re-election at the Company’s 2024 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923012904/0001437749-23-012904-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will not stand for re-election and will resign"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}